7Baggers

Puma Biotechnology Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -44.67-24.13-3.5916.9437.4858.0278.5699.1Milllion

Puma Biotechnology Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2011-12-31 
  revenue72,178,000 56,116,000 54,568,000 52,775,000 65,700,000 57,102,000 59,518,000 45,736,000 55,400,000 46,245,000 53,384,000 98,169,000 52,600,000 50,754,000 70,582,000 51,217,000 62,900,000 56,400,000 53,919,000 99,100,000 71,100,000 62,600,000 50,767,000 66,516,000 21,600,000 6,077,000 -281,096 
  cost of revenue24,323,000 13,284,000 11,857,000 13,218,000 16,800,000 12,495,000 14,918,000 10,844,000 11,900,000 10,279,000 11,969,000 29,557,000 10,900,000 9,943,000 9,415,000 9,076,000 10,100,000 9,400,000 9,317,000 8,000,000 10,300,000 9,000,000 8,831,000 6,383,000 4,100,000 1,526,000 
  gross profit47,855,000 42,832,000 42,711,000 39,557,000 48,900,000 44,607,000 44,600,000 34,892,000 43,500,000 35,966,000 41,415,000 68,612,000 41,700,000 40,811,000 61,167,000 42,141,000 52,800,000 47,000,000 44,602,000 91,100,000 60,800,000 53,600,000 41,936,000 60,133,000 17,500,000 4,551,000 -281,096 
  operating expenses                           
  research and development12,873,000 11,446,000 13,357,000 12,706,000 13,800,000 11,253,000 11,966,000 15,237,000 14,200,000 18,836,000 18,638,000 20,228,000 24,200,000 23,344,000 24,691,000 25,455,000 30,200,000 30,000,000 36,855,000 35,700,000 38,400,000 36,400,000 43,245,000 46,925,000 50,200,000 49,502,000 
  sales, general and administrative                           
  total operating expenses33,057,000 33,622,000 37,819,000 35,192,000 38,900,000 35,214,000 32,542,000 35,639,000 36,700,000 44,920,000 58,048,000 48,466,000 53,000,000 52,942,000 54,038,000 56,392,000 61,500,000 61,400,000 70,382,000 81,200,000 79,400,000 64,900,000 83,380,000 83,527,000 81,100,000 81,991,000 10,141,504 
  operating income14,798,000 8,585,000 4,892,000 4,365,000 10,000,000 9,673,000 12,058,000 -684,000 6,800,000 -8,954,000 -16,633,000 20,146,000 -11,300,000 -12,131,000 7,129,000 -16,933,000 -8,700,000 -14,400,000 -25,780,000 -10,087,000 -18,600,000 -11,300,000 -41,444,000 -23,394,000 -63,600,000 -77,440,000 -10,141,504 
  net income12,268,000 5,796,000 2,126,000 1,401,000 -5,600,000 -360,000 9,371,000 -3,403,000 4,200,000 -44,672,000 -5,106,000 16,528,000 -15,000,000 -31,463,000 3,395,000 -16,933,000 -11,200,000 -16,900,000 -37,424,000 -10,100,000 -30,700,000 -14,200,000 -44,335,000 -24,345,000 -64,100,000 -77,180,000 -10,217,721 

We provide you with 20 years income statements for Puma Biotechnology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Puma Biotechnology stock. Explore the full financial landscape of Puma Biotechnology stock with our expertly curated income statements.

The information provided in this report about Puma Biotechnology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.